Journal of Shanghai Jiao Tong University (Medical Science) ›› 2024, Vol. 44 ›› Issue (7): 922-927.doi: 10.3969/j.issn.1674-8115.2024.07.014
• Review • Previous Articles
ZHU Mingyang(), XU Yuanyuan, REN Jianghao, HUANG Jiazheng, LI Ruonan, TAN Qiang()
Received:
2023-10-29
Accepted:
2024-04-22
Online:
2024-07-28
Published:
2024-07-28
Contact:
TAN Qiang
E-mail:cangzhouyuhe@hotmail.com;dr_tanqiang@sina.cn
Supported by:
CLC Number:
ZHU Mingyang, XU Yuanyuan, REN Jianghao, HUANG Jiazheng, LI Ruonan, TAN Qiang. Review of sublobar resection for lung adenocarcinoma with ground-glass presence[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(7): 922-927.
Add to citation manager EndNote|Ris|BibTeX
URL: https://xuebao.shsmu.edu.cn/EN/10.3969/j.issn.1674-8115.2024.07.014
1 | SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. |
2 | THAI A A, SOLOMON B J, SEQUIST L V, et al. Lung cancer[J]. Lancet, 2021, 398(10299): 535-554. |
3 | HANSELL D M, BANKIER A A, MACMAHON H, et al. Fleischner society: glossary of terms for thoracic imaging[J]. Radiology, 2008, 246(3): 697-722. |
4 | COLLINS J, STERN E J. Ground-glass opacity at CT: the ABCs[J]. AJR Am J Roentgenol, 1997, 169(2): 355-367. |
5 | SUZUKI K, ASAMURA H, KUSUMOTO M, et al. “Early” peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan[J]. Ann Thorac Surg, 2002, 74(5): 1635-1639. |
6 | KIM Y T. Management of ground-glass nodules: when and how to operate?[J]. Cancers, 2022, 14(3): 715. |
7 | PEDERSEN J H, SAGHIR Z, WILLE M M, et al. Ground-glass opacity lung nodules in the era of lung cancer CT screening: radiology, pathology, and clinical management[J]. Oncology, 2016, 30(3): 266-274. |
8 | NAKATA M, SAEKI H, TAKATA I, et al. Focal ground-glass opacity detected by low-dose helical CT[J]. Chest, 2002, 121(5): 1464-1467. |
9 | ENGELER C E, TASHJIAN J H, TRENKNER S W, et al. Ground-glass opacity of the lung parenchyma: a guide to analysis with high-resolution CT[J]. AJR Am J Roentgenol, 1993, 160(2): 249-251. |
10 | KURIYAMA K, SETO M, KASUGAI T, et al. Ground-glass opacity on thin-section CT: value in differentiating subtypes of adenocarcinoma of the lung[J]. AJR Am J Roentgenol, 1999, 173(2): 465-469. |
11 | KODAMA K, HIGASHIYAMA M, YOKOUCHI H, et al. Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning[J]. Lung Cancer, 2001, 33(1): 17-25. |
12 | KIM E A, JOHKOH T, LEE K S, et al. Quantification of ground-glass opacity on high-resolution CT of small peripheral adenocarcinoma of the lung: pathologic and prognostic implications[J]. AJR Am J Roentgenol, 2001, 177(6): 1417-1422. |
13 | CHO S, YANG H, KIM K, et al. Pathology and prognosis of persistent stable pure ground-glass opacity nodules after surgical resection[J]. Ann Thorac Surg, 2013, 96(4): 1190-1195. |
14 | WOOD D E, KAZEROONI E A, BAUM S L, et al. Lung cancer screening, version 3.2018, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2018, 16(4): 412-441. |
15 | HERBST R S, MORGENSZTERN D, BOSHOFF C. The biology and management of non-small cell lung cancer[J]. Nature, 2018, 553(7689): 446-454. |
16 | REA G, RUDRAPPA M. Lobectomy [M]. StatPearls. Treasure Island (FL): StatPearls Publishing: 2022. |
17 | CAHAN W G. Radical lobectomy[J]. J Thorac Cardiovasc Surg, 1960, 39: 555-572. |
18 | GINSBERG R J, RUBINSTEIN L V. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Lung Cancer Study Group[J]. Ann Thorac Surg, 1995, 60(3): 615-622; discussion 622-623. |
19 | LANDRENEAU R J, SUGARBAKER D J, MACK M J, et al. Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer[J]. J Thorac Cardiovasc Surg, 1997, 113(4): 691-698; discussion 698-700. |
20 | STRAND T E, ROSTAD H, MØLLER B, et al. Survival after resection for primary lung cancer: a population based study of 3211 resected patients[J]. Thorax, 2006, 61(8): 710-715. |
21 | SCOTT W J, HOWINGTON J, FEIGENBERG S, et al. Treatment of non-small cell lung cancer stage I and stage II: accp evidence-based clinical practice guidelines (2nd edition)[J]. Chest, 2007, 132(3 Suppl): 234S-242S. |
22 | POSTMUS P E, KERR K M, OUDKERK M, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): esmo Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2017, 28(suppl_4): iv1-iv21. |
23 | JENSIK R J, FABER L P, MILLOY F J, et al. Segmental resection for lung cancer. a fifteen-year experience[J]. J Thorac Cardiovasc Surg, 1973, 66(4): 563-572. |
24 | AOKAGE K, YOSHIDA J, HISHIDA T, et al. Limited resection for early-stage non-small cell lung cancer as function-preserving radical surgery: a review[J]. Jpn J Clin Oncol, 2017, 47(1): 7-11. |
25 | WARREN W H, FABER L P. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. five-year survival and patterns of intrathoracic recurrence[J]. J Thorac Cardiovasc Surg, 1994, 107(4): 1087-1093; discussion 1093-1094. |
26 | SIENEL W, STREMMEL C, KIRSCHBAUM A, et al. Frequency of local recurrence following segmentectomy of stage IA non-small cell lung cancer is influenced by segment localisation and width of resection margins: implications for patient selection for segmentectomy[J]. Eur J Cardiothorac Surg, 2007, 31(3): 522-527;discussion 527-528. |
27 | OU S H, ZELL J A, ZIOGAS A, et al. Prognostic factors for survival of stage I nonsmall cell lung cancer patients: a population-based analysis of 19, 702 stage I patients in the California Cancer Registry from 1989 to 2003[J]. Cancer, 2007, 110(7): 1532-1541. |
28 | BANDO T, YAMAGIHARA K, OHTAKE Y, et al. A new method of segmental resection for primary lung cancer: intermediate results[J]. Eur J Cardiothorac Surg, 2002, 21(5): 894-899; discussion900. |
29 | BANDO T, MIYAHARA R, SAKAI H, et al. A follow-up report on a new method of segmental resection for small-sized early lung cancer[J]. Lung Cancer, 2009, 63(1): 58-62. |
30 | WATANABE S, WATANABE T, ARAI K, et al. Results of wedge resection for focal bronchioloalveolar carcinoma showing pure ground-glass attenuation on computed tomography[J]. Ann Thorac Surg, 2002, 73(4): 1071-1075. |
31 | EL-SHERIF A, FERNANDO H C, SANTOS R, et al. Margin and local recurrence after sublobar resection of non-small cell lung cancer[J]. Ann Surg Oncol, 2007, 14(8): 2400-2405. |
32 | OKADA M, NISHIO W, SAKAMOTO T, et al. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection[J]. J Thorac Cardiovasc Surg, 2005, 129(1): 87-93. |
33 | SAKURAI H, DOBASHI Y, MIZUTANI E, et al. Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment[J]. Ann Thorac Surg, 2004, 78(5): 1728-1733. |
34 | YAMADA S, KOHNO T. Video-assisted thoracic surgery for pure ground-glass opacities 2 cm or less in diameter[J]. Ann Thorac Surg, 2004, 77(6): 1911-1915. |
35 | SAWABATA N, OHTA M, MATSUMURA A, et al. Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study[J]. Ann Thorac Surg, 2004, 77(2): 415-420. |
36 | SCHUCHERT M J, PETTIFORD B L, KEELEY S, et al. Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer[J]. Ann Thorac Surg, 2007, 84(3): 926-933. |
37 | LI X F, REN F, WANG S H, et al. The epidemiology of ground glass opacity lung adenocarcinoma: a network-based cumulative meta-analysis[J]. Front Oncol, 2020, 10: 1059. |
38 | NAKAMURA H, SAJI H, OGATA A, et al. Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resection[J]. Lung Cancer, 2004, 44(1): 61-68. |
39 | TSUTANI Y, MIYATA Y, NAKAYAMA H, et al. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy[J]. Chest, 2014, 145(1): 66-71. |
40 | NAKATA M, SAWADA S, YAMASHITA M, et al. Objective radiologic analysis of ground-glass opacity aimed at curative limited resection for small peripheral non-small cell lung cancer[J]. J Thorac Cardiovasc Surg, 2005, 129(6): 1226-1231. |
41 | NAKAYAMA H, YAMADA K, SAITO H, et al. Sublobar resection for patients with peripheral small adenocarcinomas of the lung: surgical outcome is associated with features on computed tomographic imaging[J]. Ann Thorac Surg, 2007, 84(5): 1675-1679. |
42 | OKADA M, NAKAYAMA H, OKUMURA S, et al. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma[J]. J Thorac Cardiovasc Surg, 2011, 141(6): 1384-1391. |
43 | WILSHIRE C L, LOUIE B E, MANNING K A, et al. Radiologic evaluation of small lepidic adenocarcinomas to guide decision making in surgical resection[J]. Ann Thorac Surg, 2015, 100(3): 979-988. |
44 | ASAMURA H, CHANSKY K, CROWLEY J, et al. The international association for the study of lung cancer lung cancer staging project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer[J]. J Thorac Oncol, 2015, 10(12): 1675-1684. |
45 | MACCHIARINI P, FONTANINI G, HARDIN M J, et al. Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer[J]. J Thorac Cardiovasc Surg, 1993, 106(1): 80-89. |
46 | ICHINOSE Y, YANO T, YOKOYAMA H, et al. The correlation between tumor size and lymphatic vessel invasion in resected peripheral stage I non-small-cell lung cancer. A potential risk of limited resection[J]. J Thorac Cardiovasc Surg, 1994, 108(4): 684-686. |
47 | KOIKE T, TERASHIMA M, TAKIZAWA T, et al. Clinical analysis of small-sized peripheral lung cancer[J]. J Thorac Cardiovasc Surg, 1998, 115(5): 1015-1020. |
48 | MATSUGUMA H, YOKOI K, ANRAKU M, et al. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: a predictor of lymph node metastasis[J]. J Thorac Cardiovasc Surg, 2002, 124(2): 278-284. |
49 | OHDE Y, NAGAI, YOSHIDA J, et al. The proportion of consolidation to ground-glass opacity on high resolution CT is a good predictor for distinguishing the population of non-invasive peripheral adenocarcinoma[J]. Lung Cancer, 2003, 42(3): 303-310. |
50 | SUZUKI K, KOIKE T, ASAKAWA T, et al. A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201)[J]. J Thorac Oncol, 2011, 6(4): 751-756. |
51 | TRAVIS W D, BRAMBILLA E, NOGUCHI M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary[J]. Proc Am Thorac Soc, 2011, 8(5): 381-385. |
52 | RUSSELL P A, WAINER Z, WRIGHT G M, et al. Does lung adenocarcinoma subtype predict patient survival? : a clinicopathologic study based on the new international association for the study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification[J]. J Thorac Oncol, 2011, 6(9): 1496-1504. |
53 | MANDREKAR J N. Simple statistical measures for diagnostic accuracy assessment[J]. J Thorac Oncol, 2010, 5(6): 763-764. |
54 | SUZUKI K, WATANABE S I, WAKABAYASHI M, et al. A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer[J]. J Thorac Cardiovasc Surg, 2022, 163(1): 289-301.e2. |
55 | SAJI H, OKADA M, TSUBOI M, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial[J]. Lancet, 2022, 399(10335): 1607-1617. |
56 | MACMAHON H, NAIDICH D P, GOO J M, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the fleischner society 2017[J]. Radiology, 2017, 284(1): 228-243. |
57 | SUZUKI K, SAJI H, AOKAGE K, et al. Comparison of pulmonary segmentectomy and lobectomy: safety results of a randomized trial[J]. J Thorac Cardiovasc Surg, 2019, 158(3): 895-907. |
58 | HUANG T W, LIN K H, HUANG H K, et al. The role of the ground-glass opacity ratio in resected lung adenocarcinoma[J]. Eur J Cardiothorac Surg, 2018, 54(2): 229-234. |
59 | KOIKE W, IWANO S, MATSUO K, et al. Doubling time calculations for lung cancer by three-dimensional computer-aided volumetry: effects of inter-observer differences and nodule characteristics[J]. J Med Imaging Radiat Oncol, 2014, 58(1): 82-88. |
60 | CHANG B, HWANG J H, CHOI Y H, et al. Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan[J]. Chest, 2013, 143(1): 172-178. |
[1] | WANG Mengfei, YANG Shouzhi, QIAO Yongxia, HUANG Lin. Establishment of discriminative models for predicting the infiltration degree of patients with lung adenocarcinoma based on clinical laboratory indicators [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(1): 98-107. |
[2] | HUANG Huayan, XU-ZHANG Wendi, XIA Liliang, YU Yongfeng, LU Shun. Advances in immunotherapy of advanced non-small cell lung cancer with EGFR mutation [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(5): 611-618. |
[3] | ZHAO Zhuoming, LIU Zhenhao, LU Manman, ZHANG Yu, XU Linfeng, XIE Lu. Analysis of tumor-related features of non-small cell lung cancer based on TCR repertoire workflow [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(12): 1520-1528. |
[4] | LIAO Yahui, LIU Liyun, ZHU Hongrui, LIN Houwen, YAN Jizhou, SUN Fan. Marine sponge-derived smenospongine overcomes resistance of cisplatin via inhibiting EGFR-Akt-ABCG2 pathway in NSCLC cells [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(8): 997-1007. |
[5] | LIU Ziyang, WANG Xiaowen, CHEN Li. lncRNA GK-IT1 influences the carcinogenesis of non-small cell lung cancer cells through regulating aldolase A [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(5): 591-601. |
[6] | LU Wenqing, MENG Zhouwenli, YU Yongfeng, LU Shun. Resistance mechanisms and overcoming strategies of the third-generation EGFR-TKI in non-small cell lung cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(4): 535-544. |
[7] | ZHAO Xue, DONG Chunyan. Correlation of WD 40 repeat 43 expression in lung adenocarcinoma and its effect on paclitaxel-resistance of cells [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(12): 1656-1665. |
[8] | LI Ruonan, CHEN Xiaoke, XU Yuanyuan, TAN Qiang. Advances in postoperative adjuvant targeted therapy for patients with stage ⅠB-ⅢA non-small cell lung cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(11): 1612-1619. |
[9] | Yu ZHANG, Xiaoyuan WU, Lihua GUAN, Yiyuan LIU, Xingyue PENG, Haiyan XIE, Wei HU, Keke HAO, Ning XIA, Guojun LU, Zhibo HOU. Application of high-throughput drug sensitivity screening system in the treatment of non-small cell lung cancer with malignant pleural effusion [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2022, 42(1): 82-89. |
[10] | Lei XIONG, Qian YI, Ming-fang XU, Jian CHEN. Expression and prognosis analysis of MRPL12 in lung adenocarcinoma [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(8): 1033-1040. |
[11] | Yun-fang MA, Li-na PAN, Zhen LI, Bei-li GAO, Jia-an HU, Zhi-hong XU. Exploratory study on downregulation of PD-L1 in KRAS G12V-mutant non-small cell lung cancer cells by selumetinib [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 741-748. |
[12] | CHEN Liang, WANG Zhe-xin, YAO Feng. Analysis of clinicopathological factors of spread through air spaces in stage Ⅰ A lung adenocarcinoma [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(7): 957-961. |
[13] | ZHANG Wei-ran1, 2, LIN Xue-feng3, LI Xin2, ZHANG Hao2, WANG Meng2, SUN Wei2, HAN Xing-peng2, SUN Da-qiang1, 4. Transcriptional identification of potential biomarkers of lung adenocarcinoma [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(12): 1598-1606. |
[14] | QU Guo-jun1, LU Yuan-feng2, LI Yu1. Mechanism of CCT2, a new downstream substrate of PDGFRα, on proliferation of tumor cells [J]. , 2019, 39(1): 28-. |
[15] | HE Ya-ping1, LOU Wei-qun2, CHEN Jie-ling2, ZHOU Zhen3, ZHU Jing-fen1, JIAN Hong3. Influencing factors for quality of life in patients over 12 months after diagnosis of non-small cell lung cancer [J]. , 2018, 38(7): 775-. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||